EPRX Eupraxia Pharmaceuticals Inc.
Company Analysis
Latest News
🟢 Eupraxia Pharmaceuticals Inc. is trading 5.29% up
EPRX is trading at $6.57, up 5.29%.
Eupraxia Reshuffles Its Leadership and Moves to Seattle — But Can a Management Overhaul Justify a 12% Pop for a Pre-Revenue Biotech?
Shares of Eupraxia Pharmaceuticals (EPRX) surged 12.2% in pre-market trading to $7.00, rebounding sharply from a choppy week that saw the stock bounce between...
🟢 Eupraxia Pharmaceuticals is trading 12.2% up today following leadership and operations updates
Eupraxia Pharmaceuticals is trading 12.2% up at $7.00 in pre-market, rebounding from recent weakness and moving back above last week’s range. • The move...
🔴 Eupraxia Pharmaceuticals is trading 5% down today following last week's rebound
Eupraxia Pharmaceuticals is trading 5% down at $6.26 today, likely seeing profit-taking following last week's sector-driven rebound. • No fresh...
🟢 Eupraxia Pharmaceuticals is trading 5% up today on broader healthcare sector rotation
Eupraxia Pharmaceuticals is trading 5% up today at $6.47, rebounding from yesterday’s 5.5% drop as investors shift into defensive healthcare names. • The move...
🔴 Eupraxia Pharmaceuticals is trading 5.1% down today amid broader market weakness
Eupraxia Pharmaceuticals is trading 5.1% down at $6.34 today as broader market weakness and risk-off sentiment weigh on the stock. • Shares are retracing...
🟢 Eupraxia Pharmaceuticals is trading 5.6% up today on sustained bullish analyst coverage and financing momentum
Eupraxia Pharmaceuticals is trading at $7.30 (5.6% up) in pre-market as investors respond to a wave of positive analyst coverage and recent financing...
🟢 Eupraxia Pharmaceuticals is trading 5.5% up today, extending a multi-day rebound following bullish analyst coverage
Eupraxia Pharmaceuticals is trading at $7.30 (5.5% up) in pre-market, extending its multi-day rebound from late June levels as investors react to sustained...
🟢 EPRX is trading 7.4% up today as Eupraxia Pharmaceuticals appoints three new directors to its Board
• Eupraxia Pharmaceuticals (NASDAQ:EPRX) announced today the appointment of Robert Bazemore, Amy Pott, and Dr. Helen Thackray to its Board of Directors. • The...
🟢 EPRX is trading 5.8% up today on continued biotech sector momentum
EPRX is trading at $6.97 (5.8% up) in pre-market, extending strength seen during the recent biotech-led rally. • The move appears tied to continued positive...
🟢 EPRX is trading 14.7% up today on bullish biotech sentiment and risk-on market moves
EPRX is trading at $7.56 (14.7% up) in after-hours trading, extending strong gains from the regular session amid a broader rally in biotechnology stocks. •...
🟢 EPRX is trading 10.5% up today with no clear company-specific catalyst found
EPRX is trading at $7.30 (10.54% up) in pre-market action despite a lack of major company-specific announcements, earnings releases, or regulatory updates to...
🟢 Eupraxia Pharmaceuticals Inc. is trading 10.88% up in pre-market
EPRX is trading at $6.93, up 10.88% in pre-market.
🔴 EPRX is trading 5.3% down today amid broader risk-off sentiment
EPRX is trading 5.3% down at $6.29 today, pulling back alongside other growth and tech-related names amid a broader risk-off market tone. • The decline...
🟢 Eupraxia Pharmaceuticals Inc. is trading 8.5% up today extending its rebound on momentum and a risk-on market backdrop
Eupraxia Pharmaceuticals Inc. is trading 8.5% up at $6.54 in pre-market, extending its rebound after closing at $6.29 on June 17, 2026. * The move appears to...
🟢 Eupraxia Pharmaceuticals Inc. is trading 5.3% up today after bouncing from a technical pullback
Eupraxia Pharmaceuticals Inc. is trading at $6.35 (up 5.31%) after bouncing from an 8.0% technical pullback on June 16, 2026. • The move appears to be a...
🔴 Eupraxia Pharmaceuticals Inc. is trading 8.0% down today in a technical pullback following recent gains
Eupraxia Pharmaceuticals Inc. is trading 8.0% down at $5.72 today in what appears to be a technical pullback following a period of short-term strength. • The...
🟢 Eupraxia Pharmaceuticals Inc. is trading 7.8% up today with no clear catalyst yet
Eupraxia Pharmaceuticals Inc. is trading 7.8% up at $6.51 in pre-market with no clear catalyst yet, extending its recent multi-day uptrend from the $5.90–$6.20...
🔴 Eupraxia Pharmaceuticals Inc. is trading 5.2% down today amid a broad market sell-off
Eupraxia Pharmaceuticals Inc. is trading 5.2% down at $6.12 amid a broad market sell-off that is pressuring risk and growth names. • The decline appears...
🟢 EPRX is trading 1% up in after-hours trading with no clear catalyst yet
EPRX is trading 1% up at $7.45 in after-hours trading on light, news-less action. • No fresh company-specific headlines, earnings, or regulatory developments...